| Date Filed | Type | Description |
| 01/05/2023 |
4
| Presnell Sharon Collins (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 36,000 restricted stock units
@ $0 |
|
| 01/06/2022 |
4
| Presnell Sharon Collins (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 18,000 options to buy
@ $1.26, valued at
$22.7k
|
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/30/2020 |
4
| Presnell Sharon Collins (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 330,000 options to buy
@ $0.51, valued at
$168.3k
|
|
| 10/30/2020 |
3
| Presnell Sharon Collins (Director) has filed a Form 3 on VIVEVE MEDICAL, INC. |
| 11/20/2018 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 11,200 shares
@ $1.0673, valued at
$12k
|
|
| 11/13/2018 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Sold 40,000 shares
@ $1.27, valued at
$50.8k
|
|
| 08/16/2018 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 11,655 shares
@ $1.1075, valued at
$12.9k
Granted 675,000 options to buy
@ $1.135, valued at
$766.1k
|
|
| 05/29/2018 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 74,380 shares
@ $0
Granted 300,000 options to buy
@ $1.84, valued at
$552k
|
|
| 05/17/2018 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 8,325 shares
@ $1.6621, valued at
$13.8k
|
|
| 02/20/2018 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 9,420 shares
@ $1.0855, valued at
$10.2k
|
|
| 11/16/2017 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 5,860 shares
@ $1.4702, valued at
$8.6k
|
|
| 08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/09/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/13/2016 |
4
| Presnell Sharon Collins (Chief Scientific Officer) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $3.99, valued at
$399k
|
|
| 06/08/2015 |
4
| Presnell Sharon Collins (EVP, Research & Dev & CTO) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 130,000 options to buy
@ $4.92, valued at
$639.6k
|
|
| 03/16/2015 |
4
| Presnell Sharon Collins (EVP, Research & Dev & CTO) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Exercised 50,000 options to buy
@ $0.08, valued at
$4k
|
|
| 10/08/2014 |
4
| Presnell Sharon Collins (EVP, Research & Dev & CTO) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Sold 50,000 shares
@ $6.1095, valued at
$305.5k
|
|
| 02/21/2014 |
4
| Presnell Sharon Collins (EVP, Research & Dev & CTO) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 155,000 options to buy
@ $9.86, valued at
$1.5M
|
|
| 10/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2013 |
4
| Presnell Sharon Collins (EVP, Research & Dev & CTO) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 100,000 options to buy
@ $3.93, valued at
$393k
|
|
| 08/08/2012 |
4
| Presnell Sharon Collins (EVP, Research & Dev & CTO) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Exercised 224,064 options to buy
@ $0.08, valued at
$17.9k
|
|
| 03/13/2012 |
3
| Presnell Sharon Collins (EVP, Research & Development) has filed a Form 3 on ORGANOVO HOLDINGS, INC. |